David Rowbotham
Auckland City Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Rowbotham.
British Journal of Surgery | 2016
Ryash Vather; Gregory O'Grady; John W. Arkwright; David Rowbotham; Leo K. Cheng; Philip G. Dinning; Ian P. Bissett
Colorectal resections alter colonic motility, including disruption of control by neural or bioelectrical cell networks. The long‐term impact of surgical resections and anastomoses on colonic motor patterns has, however, never been assessed accurately. Fibreoptic high‐resolution colonic manometry was employed to define motility in patients who had undergone distal colorectal resection.
General Hospital Psychiatry | 2017
Stephen West; David Rowbotham; Glen L. Xiong; Chris Kenedi
OBJECTIVE The haematological and cardiac complications of clozapine have been well documented. Recent evidence from pharmacovigilance databases suggests that gastrointestinal (GI) complications are the leading cause of clozapine related deaths. This review aims to describe clinical features along with preventative and treatment options. METHOD A review of MEDLINE via PubMed searching for all articles published up to February of 2016. Inclusion criteria were articles that provided clinical or epidemiological information relating to the diagnosis, outcome, management or pathophysiology of clozapine related gastrointestinal disorders in humans. RESULTS Three large case series were identified with 104 cases, 20 of these reported clinical details. A further 52 cases reports were included. Median age was 40, with 79% being male, mean daily clozapine dose was 453 mg. Mortality was 38% with survivors being younger (39 vs. 42), on lower daily doses (400 mg vs. 532 mg), more likely to be female (32% vs. 6%). Four patients were re-challenged with clozapine following CIGH, two suffered a recurrence. CONCLUSION Risk factors for CIGH appear to be older age, male gender, patients in the first four months of treatment, co-prescription of constipating agents, higher daily dose of clozapine, and previous CIGH. Risk factors for death were older age and male gender. Patients receiving clozapine should be counselled about the dangers of constipation and to report new GI symptoms. Once severe CIGH has occurred clozapine should be halted and reviewed with bowel symptoms managed promptly. Re-challenging with clozapine may present substantial risks due to the severity of CIGH and a paucity of evidence. From the available evidence a treatment strategy has been proposed. Further prospective data regarding CIGH are needed to allow a better assessment of the scale of the problem with the development and testing of treatment strategies.
Anz Journal of Surgery | 2015
Rebekah Jaung; Jason P. Robertson; Ryash Vather; David Rowbotham; Ian P. Bissett
Acute diverticulitis (AD) is one of the most common acute admission diagnoses for general surgery, and its prevalence is increasing, in part due to the ageing population. Currently, most patients who present to a tertiary hospital are admitted for a period of treatment and observation. Simple, safe and cost‐effective strategies for improving our current treatment of this condition will be invaluable in providing the most appropriate management for individual patients and for reducing the health resources expended on hospital admissions and parenteral antibiotics. AD can be categorized as uncomplicated or complicated, these two subtypes have a very different clinical course. The management of uncomplicated AD has become increasingly conservative, with a focus on symptomatic relief and supportive management. Recent research has brought into question the need for extended hospital admission and questioned the current use of antibiotics. Anti‐inflammatory agents that reduce local inflammation in uncomplicated AD may be a useful means of reducing damage caused by inflammation and aiding earlier resolution of the inflammatory response and associated symptoms. Mesalazine is an anti‐inflammatory agent that has been trialled in uncomplicated AD. Mesalazine has been shown to improve time to resolution of endoscopic and histological evidence of inflammation following an episode of AD and also reduce the rate of recurrence. In this literature review, we provide an overview of recent advances in AD classification, pathophysiology and management, and examine the possibility of introducing the use of anti‐inflammatory agents in the management of uncomplicated AD.
British Journal of Surgery | 2018
Ryash Vather; Gregory O'Grady; Anthony Y. Lin; Peng Du; C. I. Wells; David Rowbotham; John W. Arkwright; Leo K. Cheng; Philip G. Dinning; Ian P. Bissett
Recovery after colonic surgery is invariably delayed by disturbed gut motility. It is commonly assumed that colonic motility becomes quiescent after surgery, but this hypothesis has not been evaluated rigorously. This study quantified colonic motility through the early postoperative period using high‐resolution colonic manometry.
Neurogastroenterology and Motility | 2016
Ryash Vather; Gregory O'Grady; Anthony Y. Lin; David Rowbotham; Peng Du; Philip Dinning; Ian P. Bissett
11.
The New Zealand Medical Journal | 2016
Rebekah Jaung; Jason P. Robertson; David Rowbotham; Ian P. Bissett
World Journal of Surgery | 2017
Rebekah Jaung; Malsha Kularatna; Jason P. Robertson; Ryash Vather; David Rowbotham; Andrew D. MacCormick; Ian P. Bissett
Journal of Surgical Research | 2018
Andrei M. Beliaev; Michael Booth; David Rowbotham; Colleen Bergin
General Hospital Psychiatry | 2017
Stephen West; David Rowbotham; Glen L. Xiong; Chris Kenedi
Colorectal Disease | 2017
Rebekah Jaung; Jason P. Robertson; Gregory O'Grady; Tony Milne; David Rowbotham; Ian P. Bissett